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S U M M A R Y
Background: The delay in diagnosis and treatment of tuberculous meningitis (TBM) is a major factor in
the high mortality observed with this pathology. The distinction between bacterial meningitis (BM) and
TBM by clinical features alone is often impossible, and the available biological resources remain
inadequate or inaccessible, especially in developing countries. We attempted to develop a simple
diagnostic algorithm on the basis of clinical and laboratory ﬁndings that could be used as an early
predictor of TBM in adult patients in Morocco.
Methods: We compared the clinical and laboratory features on admission of 508 adults in a medical
intensive care unit in Morocco who satisﬁed diagnostic criteria for tuberculous (n = 274) or bacterial
(n = 234) meningitis. Features independently predictive of TBM were modeled by multivariate logistic
regression to create a diagnostic rule, and by a classiﬁcation and regression tree (CART).
Results: Six features were predictive of a diagnosis of TBM: female gender, duration of symptoms, the
presence of localizing signs, white blood cell (WBC) count, the level of serum sodium, and the total
cerebrospinal ﬂuid WBC count. The sensitivity for CART was 87% and for a score >7 was 88%; speciﬁcity
was 96% and 95%, respectively. The internal validation was excellent for both diagnostic methods, with a
receiver operating characteristic (ROC) area of 0.906 bootstrap samples for a score >7 and 0.910 for
CART.
Conclusions: The clinical and laboratory parameters identiﬁed in this study may help the clinician with
the empiric diagnosis of TBM and could be used in settings with limited microbiological diagnostic
support.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Tuberculous meningitis (TBM) continues to be a common form
of central nervous system (CNS) infection in many developing
countries where tuberculosis is highly endemic. Despite anti-
tuberculosis chemotherapy, death or severe disabilities occur in
more than 50% of patients.1 It has been clearly demonstrated that
delays in diagnosis and treatment are major factors in determining
the outcome.2–6 The deﬁnitive diagnosis of TBM is made by
isolation of Mycobacterium tuberculosis from the cerebrospinal
ﬂuid (CSF), by direct staining, or by culture. However, Ziehl–
Neelsen smear sensitivity can vary between 10% and 60% and
culture positivity rates are between 25% and 75%, but results are
only available after 2–6 weeks of incubation.5 Increasing the CSF* Corresponding author.
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increases the sensitivity of smear microscopy (to 60%).7 Many
newer tests have been developed for the early diagnosis of TBM,
such as PCR, interferon-gamma release assays (IGRAs), and
tuberculostearic acid and adenosine deaminase in CSF. In a large,
multi-country study, Boehme et al. evaluated an automated
tuberculosis assay (Xpert MTB/RIF) for the presence of M.
tuberculosis and resistance to rifampin (RIF). This assay identiﬁed
98% of patients with smear-positive and culture-positive tubercu-
losis and correctly identiﬁed 98% of bacteria that were resistant to
rifampin.8 However, these tests have not been assessed completely
and are not available in the developing world where most cases of
the disease are seen.9 Given the fatal consequences of delayed
treatment, clinicians frequently initiate empirical therapy in the
setting of compatible clinical, epidemiological, and laboratory
ﬁndings.
Both the clinical presentation and biochemical and pathological
features of CSF in TBM are similar to those of many other infectionsses. Published by Elsevier Ltd. All rights reserved.
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well as non-infectious inﬂammatory diseases of the CNS.5,10
Radiological diagnostic methods (computer tomography (CT) and
especially magnetic resonance imaging) have greatly enhanced the
diagnostic accuracy of TBM, but they are still not pathognomonic
for the disease and images may not occur so early.5,11,12
Many studies have tried to identify simple clinical and CSF
ﬁndings predictive of an early diagnosis of TBM in areas with a high
tuberculosis prevalence and limited resources, by using multivariate
logistic regression in order to develop a diagnostic rule.13–18 All of
them have had varying degrees of sensitivity and speciﬁcity and
have demonstrated that applying this diagnostic rule can help in the
early diagnosis of TBM. We aimed to develop a simple diagnostic
algorithm on the basis of clinical and laboratory ﬁndings that could
be used as an early predictor of TBM in adult patients in Morocco.
2. Methods
2.1. Patients
All patients who entered the study were admitted to the
intensive care unit (ICU) of Ibn Sina Hospital, Rabat city, Morocco.
The unit, a national reference center for the treatment of severe
meningitis, is a 12-bed adult medical ICU that admits approxi-
mately 550 patients annually; the average age of patients is 40
years. The Ibn Sina Hospital is a 1028-bed teaching hospital that
provides tertiary care for the local community and the north-west
of Morocco for adult patients (>15 years old) with a wide range of
medical and surgical issues. Clinical data were recorded retro-
spectively for all patients admitted to the ICU with a diagnosis of
meningitis between 1999 and 2007.
2.2. Procedures
Each patient underwent standard history-taking, examination,
and baseline investigations (including lumbar puncture, chest
radiography, and CT of the head when indicated). CSF was
examined by microscopy with Gram and Ziehl–Neelsen stains. A
portion was cultured on blood and chocolate agar and on
Lowenstein–Jensen medium. Testing for HIV infection was
performed in 20% of cases, at the discretion of the attending
clinician. Patients with culture-proven or suspected bacterial
meningitis (BM) received 10–14 days of intravenous ampicillin
12 g per day, or ceftriaxone 2 g twice per day. Those with suspected
TBM received four drugs (rifampin, isoniazid, pyrazinamide, andFigure 1. Diagnostic criteria for tuberethambutol) for 2 months, followed by two drugs (rifampin and
isoniazid) for 10 months.
2.3. Diagnostic criteria
Diagnostic criteria for TBM and BM were applied to all patients
admitted to the medical ICU for meningitis.
Patients were diagnosed as having TBM if M. tuberculosis was
isolated in the CSF, or if patients had clinical meningitis with
negative Gram stain and sterile culture and at least one of the
following criteria: extraneurological tuberculosis, cranial CT scan
consistent with hydrocephalus and basal meningeal enhancement,
and a good response to anti-tuberculosis chemotherapy.
Patients were diagnosed as having BM if pathogenic bacteria
were isolated from CSF, or if patients had clinical meningitis with
all of the following: neutrophils and lymphocytes in the CSF, a low
concentration of glucose in the CSF (<50% of that in blood), and a
full recovery without anti-tuberculosis drugs. The criteria are
presented in Figure 1.
2.4. Statistical analysis
Results are expressed as the median and interquartile range, or
as percentages when appropriate. The two groups (TBM and BM)
were compared based on variables known in the literature to help
differentiate TBM and BM. They were recorded at ICU admission.
The features comprised clinical variables (age, sex, duration of
illness, Glasgow coma scale, and focal deﬁcits) and laboratory
variables (blood white blood cell (WBC) count, serum sodium, CSF
WBC count, CSF protein, and CSF lymphocytes).
The two groups were compared by univariate analysis using the
Mann–Whitney test for quantitative variables and the Chi-square
test for categorical variables. A p-value of <0.05 was considered
signiﬁcant. Variables signiﬁcantly related to TBM were included in
a logistic regression analysis, which was used to model the
probability of having TBM. Two methods were used for the
diagnosis of TBM: (1) the construction of a score by the method of
regression b coefﬁcients; rounded b coefﬁcients from the model
with dichotomized variables were used to deﬁne a diagnostic
index for each of the clinical variables; (2) the use of the
classiﬁcation tree (classiﬁcation and regression tree or CART).
This classiﬁcation was developed by consideration of all the
variables separately. The range of each variable was divided into
two groups to obtain the best separation between patients with
BM and those with TBM. The division corresponding to the best
separation was selected.culous and bacterial meningitis.
588 paents
38 BM excl uded : Lack of 
diagnosc cr iteria or la ck of data
42 TBM excl uded : Lack of 
diagnosc cr iteria or la ck of data
Tubercu lous Meni ngis 
n = 274
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Figure 2. Study ﬂowchart.
Table 2
Diagnostic index scores for dichotomized clinical variables used for admission
diagnostic rule
Sex b Coefﬁcient Score
Male 0 0
Female 2.123 2
Duration if illness
10 days 0 0
>10 days 2.359 2
Focal deﬁcits
Absence 0 0
Presence 2.308 2
Blood WBC count
15  109/l 0 0
<15  109/l 0.958 1
Serum sodium
130 mmol/l 0 0
<130 mmol/l 2.531 2
CSF total WBC count
400  106/l 0 0
<400  106/l 4.456 4
CSF, cerebrospinal ﬂuid; WBC, white blood cell.
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estimated by the receiver operating characteristic (ROC) curve.
The sensitivity, speciﬁcity, positive likelihood ratio, and negative
likelihood ratio were calculated for the best threshold determined
by the Youden index. An internal validation was performed by
bootstrap resampling method (1000 samples). Analyses were
conducted in SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
3. Results
Five hundred and eighty-eight patients were admitted to the
ICU with a diagnosis of meningitis during the study period; 316
patients with suspected TBM were included. Among this group, M.
tuberculosis was isolated in the CSF or at an extraneurological
location in 33.4% of cases (n = 91). Extraneurological tuberculosis
was deﬁned by the isolation of koch’s bacillus at an extraneur-
ological site (lung, lymph, or digestive tract). A single case of HIV
infection was diagnosed in the TBM group. Supportive CT
radiological evidence of TBM (hydrocephalus, and/or arachnoiditis,
and/or infarct) was diagnosed by at least one radiologist. If in
doubt, the opinion of a second radiologist was required. This
system with regard to the interpretation of CT is part of our daily
practice. These CT signs were present in 82.5% of patients (n = 225).
Two hundred and seventy-two patients were included with
suspected BM. The diagnosis of BM was conﬁrmed in 0,47 of cases
(n = 110) by direct Gram stain, culture, or the presence of soluble
Antigens in the CSF.
Forty-two patients treated for TBM and 38 patients treated for
BM were excluded because they did not meet the diagnosis studyTable 1
Univariate analysis: clinical, hematological and CSF data of patients with
tuberculous and bacterial meningitis
Tuberculous
meningitis
Bacterial
meningitis
p-Value
(n = 274) (n = 234)
Age, years 35 (27–51) 32 (21–44) 0.03
Female, n (%) 154/274 (56.2) 73/234 (31.2) <0.001
Duration of illness, days 15 (9–28) 4 (2–8) <0.001
Glasgow coma scale 13 (11–14) 14 (10–15) 0.01
Focal deﬁcits, n (%) 68/274 (24.8) 31/234 (13.2) 0.001
WBC count (109/l) 9.9 (6.9–12.5) 16.4 (11.9–22.8) <0.001
Serum sodium (mmol/l) 128 (125–132) 136 (131–139) <0.001
CSF
WBC count (106/l) 125 (50–230) 1655 (883–3725) <0.001
Protein (g/l) 1.6 (1.2–2.8) 2.3 (1.4–3) 0.9
Lymphocytes, n (%) 185/274 (67.5) 27/234 (11.5) <0.001
Results are median (interquartile range), or n (%). CSF, cerebrospinal ﬂuid; WBC,
white blood cell.criteria, or because of the lack of data. Finally, a total of 508 patients
were analyzed, of whom 274 had TBM and 234 had BM (Figure 2).
Ten clinical and laboratory features of patients with TBM
(n = 234) and BM (n = 274) were analyzed and compared to
identify features predictive of TBM.
In univariate analysis, factors with a signiﬁcant difference
between the two groups were age, female sex, stage of illness,
Glasgow coma scale, focal deﬁcits, WBC count, serum sodium, CSF
WBC count, and CSF lymphocytes (Table 1).
Those variables that were signiﬁcant in the univariate analysis
were included in a logistic regression model. Thus, a diagnostic
score for TBM (Table 2) was determined and was deﬁned by six
variables: female gender (2 points), duration of symptoms greater
than 10 days (2 points), presence of localizing signs (2 points),
blood WBC count <15  109/l (1 point), serum sodium <130
mmol/l (2 points), and a CSF total WBC count <400  106/l (4
points). Our suggested diagnostic score was therefore: if the
patient has a total score of 7, he or she has BM, and if the patient
has a score of >7, he or she has a TBM.
The results of the CART are given in Figure 3. The discriminatory
power measured by the area under the ROC curve was 0.968 for the
score and 0.969 for CART. The sensitivity for CART was 87% and for
a score >7 was 88%; speciﬁcity was 96% and 95%, the positive
likelihood ratio was 22.6 and 18.6, and the negative likelihood ratio
was 0.12 and 0.13, respectively (Table 3). The internal validation
was excellent for both diagnostic methods with a ROC area of 0.906≤ 370
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< 8  days
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Meningitis
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CSF  lymph ocytes
CSF white-ce ll cou nt
Yes No
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Figure 3. Diagnostic classiﬁcation trees for use at admission.
Table 3
Diagnostic performances
Apparent Internal validation
Score >7 CART Score >7 CART
Sensitivity 88% 87% 86% 85%
Speciﬁcity 95% 96% 93% 94%
Positive likelihood ratio 18.6 22.6 14.2 18.5
Negative likelihood ratio 0.13 0.12 0.16 0.15
ROC 0.968 0.969 0.906 0.910
CART, classiﬁcation and regression tree; ROC, receiver operating characteristic.
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was >0.80 for 100% of the samples.
4. Discussion
A positive mycobacterial culture in the CSF remains the gold
standard for the diagnosis of TBM. The sensitivity of smear
microscopy is generally low, and mycobacterial culture positivity
ranges from 50% to 75% after 8 weeks, an unacceptable length of
time for the diagnosis of tuberculosis.7 By establishing a diagnostic
score based on simple clinical and laboratory parameters, this
study has allowed a rapid diagnosis of TBM in HIV-seronegative
adult patients with good performance.
Different studies have tried to identify simple clinical and CSF
ﬁndings predictive of an early diagnosis of TBM in areas with a
high tuberculosis prevalence and limited resources, by using
multivariate logistic regression.13–18 In a pediatric hospital in
India, a study found ﬁve variables independently predictive of
TBM: report of symptoms for longer than 6 days, optic atrophy,
focal neurological deﬁcit, extrapyramidal movements, and
neutrophils forming less than half the total CSF leukocytes.13
From these ﬁndings, a diagnostic rule was developed: diagnostic
sensitivity was 98% and speciﬁcity was 44% when at least one
predictor variable was present; sensitivity was 55% and speciﬁcity
was 98% if three or more were present. Thwaites and colleagues
found ﬁve variables predictive of a diagnosis of TBM in
Vietnamese adults and developed a diagnostic rule that had a
sensitivity of 97% and a speciﬁcity of 91%.15 The applicability of
Thwaites diagnostic scoring was investigated in Turkey, a
developing country where tuberculosis is a public health problem,
and was found to be helpful in the early diagnosis of TBM.15 The
same Thwaites team reported validation of this diagnostic
algorithm using prospectively collected data from a further 205
patients admitted to the same hospital. This study shows that the
two diagnostic aids continue to perform well for the diagnosis of
TBM with a sensitivity of 99% for the logistic regression method
and 87% for the classiﬁcation tree method, in patients with
conﬁrmed TBM.16
In Egypt, researchers included pediatric and adult patients in a
similar study and identiﬁed six variables predictive of TBM. The
ﬁnding of three or more of the features revealed 93% sensitivity
and 77% speciﬁcity.17 Finally, and more recently, Vibha et al.
conﬁrmed the use of the diagnostic algorithm, which had a fair
validation in HIV-negative patients when the age factor was
excluded, with a sensitivity of 95.7% and speciﬁcity of 97.6%.18
In our study, univariate analysis of admission variables
suggested a set of potentially discriminative clinical and laboratory
features (Table 1). With the exception of the CSF protein
concentration, all variables were signiﬁcantly related to TBM.
In the multivariate logistic regression analysis, six factors were
found to be independently associated with TBM: female sex,
history of illness (>10 days), localizing signs, blood sodium (<130
mmol/l), WBC count in blood (<15  109/l), and WBC count in CSF(<400  106/l) (Table 2). The predominance of female patients
with TBM has not been recorded in other studies. In our opinion,
this feature may be due to the socio-cultural speciﬁcities of our
country. In rural settings there is a lack of health infrastructure and
women usually live in precarious and overcrowded houses, with
limited access to care. It is well known that these factors may
contribute to increased tuberculosis case rates.
The diagnostic performances were very good compared to those
found in other studies,12,13,15,17 including when internal validation
was performed.
Our study has some limitations. First, this was a retrospective
study, so many features were inaccessible and 80 patients were
excluded. Second, the rate of HIV serology performed did not
exceed 20% of the meningitis cases. However, in Morocco, the
prevalence of HIV-associated tuberculosis has remained low and
has decreased over the last decade from 0.76% in 2006 to 0.42% in
2008.19 Third, the lack of CSF culture positivity makes the ﬁnal
diagnosis of TBM less strong. Fourth, CT data for the diagnosis of
TBM have not been included in the score and CART, because
radiological scans were not performed in 24.1% (n = 66) of TBM and
40.2% (n = 94) of BM cases. Since the CT scan is easily available, its
addition to the rapid diagnosis parameters for TBM could improve
the diagnostic performance.
Finally, external validation of this score is required and a
diagnostic score for HIV-positive patients remains to be estab-
lished in Morocco.
In conclusion, the clinical and laboratory parameters identiﬁed
in this study may help the clinician with the empiric diagnosis of
TBM and could be used in settings with limited microbiological
diagnostic support so that antituberculous therapy can be
instituted rapidly until other methods of conﬁrmation are
available.
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